Blood cancer, a formidable enemy that affects countless lives, continues to cast a dark shadow over the state of Texas. As we confront this growing concern, especially during Blood Cancer Awareness Month in September, it is imperative that we raise awareness about the incidence of blood cancer and rally together to foster an environment that encourages innovative therapies and new treatments. From elected officials to the healthcare community, we must unite in our efforts to support those battling blood cancers and provide hope for a brighter future.

Blood cancer, encompassing leukemia, lymphoma, and myeloma, affects thousands of Texans each year. According to the American Cancer Society, of the 2,487 Texans diagnosed with multiple myeloma in 2022, 1,005 died from the disease, and Texas is expected to rank as the third highest in leukemia cases in 2023, with only a 66% survival rate. These statistics demand our attention and emphasize the urgent need for action.

While progress has been made in the treatment of blood cancers, there is still much ground to cover. Despite advancements, many patients face limited options, with conventional treatments often falling short in providing long-term remission or a cure. Furthermore, accessing cutting-edge therapies can be a significant challenge due to their costs and depend on the willingness of insurance to cover them.And even if approved, equitable access to care is not guaranteed. Treatment locations for individuals living in rural areas are limited and travelling to a metropolitan area can be a logistical nightmare for patients and caretakers.It is crucial that we recognize these obstacles and work toward creating an environment that supports the development and accessibility of innovative therapies.

To combat blood cancers effectively, we must advocate for policies that promote research, innovation, and affordable access to treatment. Elected officials have a vital role to play in shaping healthcare legislation that allows for the latest and most innovative treatments and therapies to make it to the patient – under the direction of their physician – where they have the greatest chance at making a difference.

The incidence of blood cancer in Texas demands our unwavering attention and concerted action. By raising awareness about this pressing issue, advocating for supportive policies, and promoting collaboration between stakeholders, we can build an environment that fosters innovation in therapies and treatments. From elected officials to the healthcare community, this month, let us come together and make a difference in the lives of those affected by blood cancers. Together, we can bring hope, improved outcomes, and a brighter future for Texans battling these devastating diseases.